TrialClinIQ | $150,000 | (Apr 29, 2026)
Lighthouse Pharmaceuticals | $12,000,000 | (Apr 29, 2026)
Windmill(US) | $12,000,000 | (Apr 29, 2026)
InfoBionic, Inc.
United States
- Waltham, Massachusetts
- 17/10/2023
- Series D
- Undisclosed Amount
InfoBionic’s MoMe® Kardia system empowers physicians with control to transform the efficiency with which they manage cardiac arrhythmia detection and monitoring processes for their patients. Leveraging a comprehensive, Cloud-based remote patient monitoring platform – the first and only of its kind – we deliver on-demand, actionable monitoring data and analytics directly to the physicians themselves.
The MoMe® Kardia 3-in-1 device streams continuous ECG, respiration, and motion data to the Cloud for analysis, and delivers automated reporting to an iPad and or a web-based portal where physicians can access and interact with the data they need, in the detail they want – anytime, anywhere.
- Industry Medical Device
- Website https://go.infobionic.com/assureme
- LinkedIn https://www.linkedin.com/company/infobionic/about/
Related People
Stuart LongFounder
United States -
Greater Boston
Experienced CEO and Mentor with a demonstrated history of rapidly scaling companies in the medical device & HCIT industry. Skilled in Enterprise & SaaS based Software & Hardware, Medical Devices, Healthcare Information Technology (HCIT). Strong professional with a focus in Marketing Strategy from Cornell University - Johnson Graduate School of Management.
IC Realtime | $2,000,000 | (Apr 29, 2026)
Hypervision Surgical | $22,962,410 | (Apr 29, 2026)
dehaze | $3,746,192 | (Apr 29, 2026)
Clarasight | $11,500,000 | (Apr 29, 2026)
Liquid Instruments | $50,000,000 | (Apr 29, 2026)
TriFetch | $1,900,000 | (Apr 28, 2026)
Linexa | $2,342,840 | (Apr 28, 2026)
HrFlow.ai | $7,000,000 | (Apr 28, 2026)